Emergent BioSolutions Inc logo

Emergent BioSolutions Inc

$ 28.43 -0.96 (-3.27%) 08:09 PM EST
On watch
P/E:
16.83
P/B:
0.93
Market Cap:
$ 1.42B
Enterprise V:
$ 1.93B
Volume:
528.86K
Avg Vol (2M):
643.10K
Also Trade In:
Volume:
528.86K
Market Cap $:
1.42B
PE Ratio:
16.83
Avg Vol (2-Month):
643.10K
Enterprise Value $:
1.93B
PB Ratio:
0.93
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Emergent BioSolutions Inc
NAICS : 325412 SIC : 2834
400 Professional Drive, Suite 400, Gaithersburg, MD, USA, 20879
Description
Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.43
Equity-to-Asset 0.55
Debt-to-Equity 0.55
Debt-to-EBITDA 2.7
Interest Coverage 6.55
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.32
Distress
Grey
Safe
Beneish M-Score -3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.91
9-Day RSI 38.14
14-Day RSI 41.85
6-1 Month Momentum % -28.1
12-1 Month Momentum % -51.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.92
Quick Ratio 2.38
Cash Ratio 1.29
Days Inventory 186.14
Days Sales Outstanding 39.51
Days Payable 60.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1

Financials (Next Earnings Date:2022-11-04 Est.)

EBS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:EBS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,602.4
EPS (TTM) ($) 1.69
Beta 0.75
Volatility % 34.11
14-Day RSI 41.85
14-Day ATR ($) 1.675984
20-Day SMA ($) 31.936
12-1 Month Momentum % -51.28
52-Week Range ($) 26.85 - 65.09
Shares Outstanding (Mil) 49.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Emergent BioSolutions Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More